Nearly 20% of all breast cancer cases are ductal PKC 412 carcinoma in situ (DCIS) with over 60 0 cases diagnosed each year. among the breast cancer community and has implications for both the patient (via adverse treatment-related effects as well as out-of-pocket costs) and society (via economic costs and the public health and environmental… Continue reading Nearly 20% of all breast cancer cases are ductal PKC